IV9 (476 - 484), HIV - 1 RT Epitope Sequence:ILKEPVHGV Motifbiotech

CRO

CDMO

CMO

Testing services

Scientific Customized Peptides

General linear peptide synthesis

Long peptide synthesis

Cyclic peptide synthesis (staple peptide)

Cyclic peptide synthesis (disulfide ring formation)

Stable isotope labeling peptide synthesis

Glycopeptides

Polypeptide modification

Peptide library synthesis

Linker Synthesis Service

ADC Linker Synthesis Service

PDC Drug Synthesis Services

FTE Services

PEPTIDE FTE

Popular peptides

Beauty peptides

Drug peptide intermediates and impurities

Cancer antigenic peptide

Catalog peptides

Linker

Synthesis of unnatural amino acids and other blocks

Human body system

HA 12CA5 Epitope

Cys-Angiopep-2

[Ala9]Autocamtide2

(Val²)-Amyloid β-Protein (1-42)

N-Acetyl lysyltyrosylcysteine amide

Acetyl-(D-Arg10,Cys11,D-Phe14,Cys17)-β-MSH (10-17) amide

MPG

Ganirelix

Bioanalytical drug development

Ac-RADARADARADARADAYKKIIKKLRGDSP-NH2

Boc-VLGR-pNA

DADE-S(OGlcNAc)-L

c(His-Phe)

Suc-GP-AMC

Cell Adhesive Peptide [RGDC]

HSV-1-amide UL 26 Open Reading Frame (242-255)

RRAAEELDSRAG-S(OGlcNAc)-PQL

Nano Peptide

DArg9

RADA16

Hel 13-5

LIVAGD

Cadherin Peptide , avian

LF-NH2

FITC-LC-TAT (47-57)

LF

Home / Peptide products / H (67 species) / HIV / IV9 (476 - 484), HIV - 1 RT Epitope

Filters

Popular peptides

Human body system

Tripeptide Peptide Tag Domain Antagonist peptides Blocker Peptides Antimicrobial peptides Amyloid peptides Inhibitor peptides Targeted Peptide Agonist Peptide

Bioanalytical drug development

RGD Peptides Glycopeptides Dipeptide Cyclodipeptide Substrate Peptide

Nano Peptide

Self-assembling peptides Cell-penetrating Peptides

Beauty peptides

Anti-aging

Anti-inflammatory

Repair

Moisturizing

Whitening

Body care

Drug peptide intermediates and impurities

Neoplasm

Diabetes mellitus

Cardiovascular

Reproductive

Anti-infection

Osteoporosis

Other

Cancer antigenic peptide

Mutation

Differentiation

Overexpressed

Tumor-specific

Catalog peptides

Linker

ADC Linker

Peptide Linker

PDC Linker

RDC linker

PROTAC linker

Reactive Linker

Alkyne Reactive Linker Amine Reactive Linker Azide Reactive Linker Click Reactive Linker Thiol Reactive Linker

Linker Intermediate

Advanced Linker Intermediate

Synthesis of unnatural amino acids and other blocks

Fmoc protects unnatural amino acids

IV9 (476 - 484), HIV - 1 RT Epitope

Support

Name IV9 (476 - 484), HIV - 1 RT Epitope	Molecular structural formula
Purity ≥95%
Formula C46H78N12O12
MW 991.21
Target HIV1
Sequence Ile-Leu-Lys-Glu-Pro-Val-His-Gly-Val
Sequence Shortening ILKEPVHGV
References [1].Epitope Escape Mutation and Decay of Human Immunodeficiency Virus Type 1-Specific CTL Responses J Immunol . 2003 Nov 15 ; 171(10) 5372 . [2].IFN-γ Exposes a Cryptic Cytotoxic T Lymphocyte Epitope in HIV-1 Reverse Transcriptase J Immunol . 1999 Jun 15 ; 162(12) 7075. [3].Lack of strong immune selection pressure by the immunodominant, HLA-A 0201-restricted cytotoxic T lymphocyte response in chronic human immunodeficiency virus-1 infection.J Clin Invest . 1998 Jun 01 ; 101(11) 2559.

* All products on our website are for scientific research and cannot be used in human body

Product details

Data download

This is a reverse transcriptase (RT) epitope (Pol residues 476-484). Within HIV-1 RT the peptide appears to be the dominant HLA A*0201-restricted epitope. Was used to investigate possible mechanisms behind HIV-1 escape from CTL. IV9 is the actual epitope processed and presented in HIV-1-infected cell lines.